Skip to main content

TIPS

  • Chapter
  • 1043 Accesses

Résumé

La dérivation porto-systémique est le traitement le plus efficace des complications de l’hypertension portale. Toutefois, les techniques chirurgicales ont été quasiment abandonnées en raison des taux élevés de mortalité et d’encéphalopathie; elles sont réservées aux rares patients à la fonction hépatique parfaitement conservée. Dans les années 1990, la dérivation porto-systémique a retrouvé sa place dans l’arsenal thérapeutique de l’hypertension portale grâce au développement de son équivalent par radiologie interventionnelle: le TIPS (transjugular intrahepatic portosystemic shunt). L’abord transjugulaire du foie avait été mis au point initialement par Hanafee et Weiner dans le cadre de la réalisation de phlébographies, de cholangiographies et de biopsies hépatiques. Le premier shunt porto-systémique intrahépatique a été créé chez le porc en 1969 par J. Rösch et al. [1].

INSERM U 858 I2MR (Institut de médecine moléculaire de Rangueil) Équipe X (Athérosclérose et artériosclérose de greffe)

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Rosch J, Hanafee WN, Snow H (1969). Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology 92(5):1112–4

    PubMed  CAS  Google Scholar 

  2. Colapinto RF, Stronell RD, Gildiner M et al. (1983). Formation of intrahepatic portosystemic shunts using a balloon dilatation catheter: preliminary clinical experience. AJR Am J Roentgenol 140(4):709–14

    Article  PubMed  CAS  Google Scholar 

  3. Palmaz JC, Sibbitt RR, Reuter SR et al. (1985) Expandable intrahepatic portacaval shunt stents: early experience in the dog. AJR Am J Roentgenol 145(4): 821–5

    Article  PubMed  CAS  Google Scholar 

  4. Richter GM, Noeldge G, Palmaz JC et al. (1990). Transjugular intrahepatic portacaval stent shunt: preliminary clinical results. Radiology 174(3 Pt 2): 1027–30

    PubMed  CAS  Google Scholar 

  5. Bureau C, Garcia-Pagan JC, Otal P et al. (2004) Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 126(2): 469–75

    Article  PubMed  Google Scholar 

  6. Semba CP, Saperstein L, Nyman U, Dake MD (1996) Hepatic laceration from wedged venography performed before transjugular intrahepatic portosystemic shunt placement. J Vasc Interv Radiol 7(1): 143–6

    Article  PubMed  CAS  Google Scholar 

  7. Krajina A, Lojik M, Chovanec V, Raupach J, Hulek P (2002) Wedged hepatic venography for targeting the portal vein during TIPS: comparison of carbon dioxide and iodinated contrast agents. Cardiovasc Intervent Radiol 25(3): 171–5

    Article  PubMed  Google Scholar 

  8. Soares GM, Murphy TP (1999) Transcaval TIPS: indications and anatomic considerations. J Vasc Interv Radiol 10(9): 1233–8

    Article  PubMed  CAS  Google Scholar 

  9. Blum U, Haag K, Rossle M et al. (1995) Noncavernomatous portal vein thrombosis in hepatic cirrhosis: treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis. Radiology 195(1):153–7

    PubMed  CAS  Google Scholar 

  10. Han G, Qi X, He C et al. (2011). Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol 54(1): 78–88

    Article  PubMed  Google Scholar 

  11. Barton RE SR, Lakin PC, Petersen BD, Keller FS (1995) TIPS: short-and long-term results: a survey of 1750 patients. Sem Interv Radiol 364–7

    Google Scholar 

  12. Malinchoc M, Kamath PS, Gordon FD et al. (2000). A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31(4):864–71

    Article  PubMed  CAS  Google Scholar 

  13. Salerno F, Camma C, Enea M et al. (2007). Transjugular intrahepatic portosystemic shunt for refractory ascites: a metaanalysis of individual patient data. Gastroenterology 133(3): 825–34

    Article  PubMed  CAS  Google Scholar 

  14. Rossle M, Siegerstetter V, Huber M, Ochs A (1998). The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver 18(2): 73–89

    PubMed  CAS  Google Scholar 

  15. Bureau C, Otal P, Chabbert V, Peron JM et al. (2002). Segmental liver ischemia after TIPS procedure using a new PTFE-covered stent. Hepatology 36(6): 1554

    PubMed  Google Scholar 

  16. Vizzutti F, Arena U, Rega L et al. (2009). Liver failure complicating segmental hepatic ischaemia induced by a PTFE-coated TIPS stent. Gut 58(4): 582–4

    Article  PubMed  CAS  Google Scholar 

  17. Ducoin H, El-Khoury J, Rousseau H et al. (1997). Histopathologic analysis of transjugular intrahepatic portosystemic shunts. Hepatology 25(5): 1064–9

    Article  PubMed  CAS  Google Scholar 

  18. Casado M, Bosch J, Garcia-Pagan JC et al. (1998). Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 114(6): 1296–303

    Article  PubMed  CAS  Google Scholar 

  19. Owens CA, Bartolone C, Warner DL et al. (1998) The inaccuracy of duplex ultrasonography in predicting patency of transjugular intrahepatic portosystemic shunts. Gastroenterology 114(5): 975–80

    Article  PubMed  CAS  Google Scholar 

  20. Bureau C, Pagan JC, Layrargues GP, et al. (2007). Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int 27(6): 742–7

    Article  PubMed  CAS  Google Scholar 

  21. Otal P, Smayra T, Bureau C et al. (2002) Preliminary results of a new expanded-polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt procedures. AJR Am J Roentgenol 178(1):141–7

    Article  PubMed  Google Scholar 

  22. Papatheodoridis GV, Goulis J, Leandro G et al. (1999). Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis. Hepatology 30(3): 612–22

    Article  PubMed  CAS  Google Scholar 

  23. Maleux G, Heye S, Verslype C, Nevens F (2007) Management of transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study. J Vasc Interv Radiol 18(8): 986–92; quiz 93

    Article  PubMed  Google Scholar 

  24. Riggio O, Ridola L, Angeloni S et al. (2010) Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial. J Hepatol 53(2): 267–72

    Article  PubMed  Google Scholar 

  25. Sanyal AJ, Reddy KR (1998) Vegetative infection of transjugular intrahepatic portosystemic shunts. Gastroenterology 115(1): 110–5

    Article  PubMed  CAS  Google Scholar 

  26. Sanyal AJ, Freedman AM, Purdum PP 3rd (1992). TIPS-associated hemolysis and encephalopathy. Ann Intern Med 117(5): 443–4

    Article  PubMed  CAS  Google Scholar 

  27. Chau TN, Patch D, Chan YW et al. (1998) «Salvage» transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 114(5): 981–7

    Article  PubMed  CAS  Google Scholar 

  28. Sanyal AJ, Freedman AM, Luketic VA et al. (1996). Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology 111(1): 138–46

    Article  PubMed  CAS  Google Scholar 

  29. Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L et al. (2004) Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 40(4): 793–801

    PubMed  Google Scholar 

  30. Garcia-Pagan JC, Caca K, Bureau C et al. (2010) Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 362(25): 2370–9

    Article  PubMed  CAS  Google Scholar 

  31. Burroughs AK, Vangeli M (2002) Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis. Scand J Gastroenterol 37(3): 249–52

    Article  PubMed  CAS  Google Scholar 

  32. Henderson JM, Boyer TD, Kutner MH et al. (2006). Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology 130(6): 1643–51

    Article  PubMed  Google Scholar 

  33. Boyer TD, Henderson JM, Heerey AM et al. (2008) Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt. J Hepatol 48(3): 407–14

    Article  PubMed  Google Scholar 

  34. Lebrec D, Vinel JP, Dupas JL (2005). Complications of portal hypertension in adults: a French consensus. Eur J Gastroenterol Hepatol 17(4): 403–10

    Article  PubMed  Google Scholar 

  35. D’Amico G, Luca A, Morabito A et al. (2005). Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. Gastroenterology 129(4): 1282–93

    Article  Google Scholar 

  36. Saab S, Nieto JM, Lewis SK, Runyon BA (2006) TIPS versus paracentesis for cirrhotic patients with refractory ascites. Cochrane Database Syst Rev (4) CD004889

    Google Scholar 

  37. Brensing KA, Textor J, Perz J et al. (2000) Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 47(2): 288–95

    Article  PubMed  CAS  Google Scholar 

  38. Gordon FD, Anastopoulos HT, Crenshaw W et al. (1997) The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology 5(6): 1366–9

    Article  Google Scholar 

  39. Peron JM, Dupuis E, Alric L et al. (1999) [Treatment by portosystemic intrahepatic shunt for refractory hydrothorax during cirrhosis]. Gastroenterol Clin Biol 3(3): 414–5

    Google Scholar 

  40. Hernandez-Guerra M, Turnes J, Rubinstein P et al. (2004) PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology 40(5): 1197–202

    Article  PubMed  Google Scholar 

  41. Plessier A, Sibert A, Consigny Y et al. (2006) Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 44(5): 1308–16

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Otal, P., Bureau, C., Lagarde, S., Mokrane, T., Vinel, JP., Rousseau, H. (2013). TIPS. In: Thérapeutiques endovasculaires des pathologies veineuses. Springer, Paris. https://doi.org/10.1007/978-2-8178-0291-6_25

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0291-6_25

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0290-9

  • Online ISBN: 978-2-8178-0291-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics